Investigational drug · Phase 2
Tavocept
Also called: LP-300, BNP7787, Dimesna
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung.
Phase 2Last checked: Nov 19, 2026Latest source record: May 4, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
6
Any phase or sponsor naming "Tavocept"
First trial start
2023
Mar 1, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Tavocept", any sponsor or status.
Conditions studied
As listed on its trial records.
- Adenocarcinoma of Lung
- Carcinoma, Non-Small-Cell Lung
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "Tavocept" as an intervention, largest first.
- Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelPivotal-lookingCompleted
BioNumerik Pharmaceuticals, Inc.Industry
NCT00039780 · 764 participants · Start Sep 2001 · Primary completion Oct 2006
Drug: BNP7787; Placebo · For: Breast Neoplasms; Breast Diseases; Metastases, Neoplasm
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus CisplatinPivotal-lookingCompleted
BioNumerik Pharmaceuticals, Inc.Industry
NCT00966914 · 540 participants · Start Apr 2010 · Primary completion Apr 2013
Drug: Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel; Placebo in combination with cisplatin and docetaxel or paclitaxel · For: Non-small Cell Lung Cancer
Sites: Birmingham, Alabama; Columbia, Missouri; Philadelphia, Pennsylvania · 42 sites in all
- Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerPivotal-lookingCompleted
Alliance for Clinical Trials in OncologyAcademic, hospital or other
NCT00077311 · 160 participants · Start Aug 2004 · Primary completion Jul 2006
Drug: darbepoetin alfa; pegfilgrastim and 3 more · For: Anemia; Drug/Agent Toxicity by Tissue/Organ; Lung Cancer and 1 more
Sites: Mountain View, California; Lewes, Delaware; Newark, Delaware · 64 sites in all
- A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaRecruiting
Lantern Pharma Inc.Industry
NCT05456256 · 90 participants (planned) · Start Mar 1, 2023 · Primary completion Dec 2026
Drug: LP-300; Pemetrexed and 1 more · For: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung
Sites: Beverly Hills, California; Fountain Valley, California; Los Alamitos, California · 16 sites in all
St. Jude Children's Research HospitalAcademic, hospital or other
NCT03849651 · 69 participants · Start Jan 31, 2019 · Primary completion Aug 7, 2024
Drug: Cyclophosphamide; Fludarabine and 9 more · For: Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS) and 5 more
Sites: Memphis, Tennessee
Roswell Park Cancer InstituteAcademic, hospital or other
NCT00003569 · 2 participants · Start Mar 1998 · Primary completion Jun 2003
Drug: cisplatin; dimesna and 1 more · For: Head and Neck Cancer; Lung Cancer; Neurotoxicity and 1 more
Sites: Chicago, Illinois; Baltimore, Maryland; Buffalo, New York
Newest research
PubMed records naming it or its code names, newest first.
- Protective Effect of Liriope platyphylla Root Extract on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.
Nam YR, Lee HJ, Park BH, et al. · J Microbiol Biotechnol 2026
- Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors.
Bodor JN, Dowell J, Treat J, et al. · Clin Lung Cancer 2025
- Ameliorative anticancer effect of dendrimeric peptide modified liposomes of letrozole: In vitro and in vivo performance evaluations.
Hegde AR, Paul M, Kumbham S, et al. · Int J Pharm 2023
- Effects of plant extracts from Stryphnodendron adstringens (mart.) coville, Lafoensia pacari a. st.-hil, copaifera spp., and Pterodon emarginatus Vogel on in vitro rumen fermentation.
Lemos BJM, Souza FM, Arnhold E, et al. · J Anim Physiol Anim Nutr (Berl) 2021
- Ultrasonography Assessments of Optic Nerve Sheath Diameter as a Noninvasive and Dynamic Method of Detecting Changes in Intracranial Pressure.
Wang LJ, Chen LM, Chen Y, et al. · JAMA Ophthalmol 2018
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.